Literature DB >> 21749391

Ferulsinaic acid attenuation of advanced glycation end products extends the lifespan of Caenorhabditis elegans.

Ahmed A R Sayed1.   

Abstract

OBJECTIVES: Ferulsinaic acid is the first member of a new rearranged class of sesquiterpene coumarins of the genus Ferula. The genus Ferula can be used for the treatment of skin infections, hysteria and for stomach disorders, such as a febrifuge and a carminative agent. The effect of ferulsinaic acid on the lifespan of the nematode Caenorhabditis elegans has been examined. Novel data explaining the effect of ferulsinaic acid on the lifespan of C. elegans and its antioxidant power were obtained.
METHODS: C. elegans was cultivated under standard laboratory conditions in absence and presence of different ferulsinaic acid. Also, animals were cultivated under heat and chemical stress conditions in absence and presence of ferulsinaic acid. Life span assay, determination of protein concentration, assay of malondialdehyde and ELISA for determination of AGEs were performed. KEY
FINDINGS: Under standard laboratory conditions and in presence of ferulsinaic acid (500 nm, 10 µm and 100 µm), mean life span of wild type animals was significantly lengthened in a dose-dependent manner from 18.64 ± 0.19 days (control) to 19 ± 0.19 (P = 0.695), 20.76 ± 0.25 (P = 0.043) and 22.3 ± 0.29 (P = 0.0291), respectively. Interestingly, in C. elegans resistance for heat stress at 35°C and oxidative stress induced by paraquat were significantly improved with ferulsinaic acid. Ferulsinaic acid was found to significantly attenuate both lipid peroxidation and the formation of advanced glycation end products in the wild-type animals under standard laboratory conditions.
CONCLUSIONS: Ferulsinaic acid had therapeutic efficacy as an antioxidant with the possibility of its use as an antioxidant drug.
© 2011 The Author. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749391     DOI: 10.1111/j.2042-7158.2010.01222.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  16 in total

Review 1.  Pharmacological lifespan extension of invertebrates.

Authors:  Mark Lucanic; Gordon J Lithgow; Silvestre Alavez
Journal:  Ageing Res Rev       Date:  2012-07-06       Impact factor: 10.895

2.  Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats.

Authors:  Ahmed Amir Radwan Sayed; Mahmoud Khalifa; Fathy Fahim Abd el-Latif
Journal:  J Physiol Biochem       Date:  2012-01-12       Impact factor: 4.158

3.  Pharmacological maintenance of protein homeostasis could postpone age-related disease.

Authors:  Silvestre Alavez; Gordon J Lithgow
Journal:  Aging Cell       Date:  2012-02-01       Impact factor: 9.304

4.  Ferulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic Kidney.

Authors:  Ahmed Amir Radwan Sayed
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

5.  Proanthocyanidin Attenuation of Oxidative Stress and NF- κ B Protects Apolipoprotein E-Deficient Mice against Diabetic Nephropathy.

Authors:  Abdulrahman L Al-Malki; Ahmed Amir Radwan Sayed; Haddad A El Rabey
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-18       Impact factor: 2.629

Review 6.  Effect of antioxidants supplementation on aging and longevity.

Authors:  Izabela Sadowska-Bartosz; Grzegorz Bartosz
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

7.  Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats.

Authors:  Abdulrahman L Al-Malki
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

8.  Bees' honey attenuation of metanil-yellow-induced hepatotoxicity in rats.

Authors:  Abdulrahman L Al-Malki; Ahmed Amir Radwan Sayed
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

9.  Oat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B.

Authors:  Abdulrahman L Al-Malki
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-10       Impact factor: 2.629

10.  Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-β.

Authors:  Abdulrahman L Al-Malki; Ahmed Amir Radwan Sayed
Journal:  BMC Complement Altern Med       Date:  2014-08-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.